Gardasil vaccination for laryngeal papillomatosis.

Gardasil vaccination for laryngeal papillomatosis. - Gardasil vaccination for laryngeal papillomatosis.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000017663

Enrollment

Registered

2015-06-01

Start date

2012-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

laryngeal papillomatosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: HPV-6 or HPV-11 positive laryngeal papillomatosis.

Exclusion criteria

Exclusion criteria: Laryngeal cancer.

Design outcomes

Primary

Measure	Time frame
Rate of recurrence	—

Secondary

Measure	Time frame
Antibody value	—

Countries

Japan

Contacts

Public ContactKiyoshi Makiyama, MD PhD

Nihon University Hospital Otorhinolaryngology

mak@med.email.ne.jp03-3293-1711

Outcome results